SCHEMBL51852

SCHEMBL51852

O=S(=O)(O)CCCCO

nearest known ligand 0.00

⚠ Novel chemotype — no close known analogue (best Tanimoto < 0.3). Unexplored chemical space relative to ChEMBL.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL3505682 0.97 APP (0.50)
SCHEMBL922968 0.97 APP (0.50)
SCHEMBL10591208 0.97 APP (0.50)
SCHEMBL841751 0.97 APP (0.50)
SCHEMBL5888595 0.97 APP (0.50)
SCHEMBL11596772 0.97 APP (0.50)
SCHEMBL9822644 0.97 APP (0.50)
SCHEMBL5888588 0.97 APP (0.50)
SCHEMBL11039416 0.97 APP (0.50)
SCHEMBL1244905 0.97 APP (0.50)

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Appears in 5137 patents — a generic fragment claimed broadly, so it's down-weighted as IP noise. Top by claim status then date:

PatentTitleAssigneePublishedPriorityFilingCountryStatus
EP-4593865-B1 PHARMACEUTICAL COMPOSITION COMPRISING NFL-TBS40-63 PEPTIDE, VARIANTS OR SALTS THEREOF AND ALANINE GLIOCURE (FR) 2026-05-06 EP claimed
WO-2026090534-A1 SULFONATED POLYPHENYLENE MEMBRANES COMPRISING ANTIOXIDANTS AND METHODS OF USE THEREOF IONOMR INNOVATIONS INC. (CA) 2026-04-30 WO claimed
WO-2026089754-A1 COMPOSITIONS AND METHODS FOR INTRANASAL DELIVERY OF THERAPEUTIC PEPTIDES Finitus, LLC (US) 2026-04-30 WO claimed
WO-2026090260-A1 STABLE ORAL LIQUID COMPOSITIONS Method Pharmaceuticals, LLC (US) 2026-04-30 WO claimed
US-20260108460-A1 STABLE ORAL LIQUID COMPOSITIONS METHOD PHARMACEUTICALS LLC (US) 2026-04-23 US claimed
US-20260108581-A1 COMPOSITIONS AND METHODS FOR MICROSPHERE DELIVERY OF CARNOSINE FOR TREATMENT OF NEURODEGENERATIVE DISEASES AND DISORDERS FINITUS LLC (US) 2026-04-23 US claimed
US-20260108467-A1 COMPOSITIONS AND METHODS FOR MICROSPHERE DELIVERY OF THERAPEUTIC PEPTIDES FINITUS LLC (US) 2026-04-23 US claimed
US-20260108583-A1 COMPOSITIONS AND METHODS FOR INTRANASAL DELIVERY OF THERAPEUTIC PEPTIDES FINITUS LLC (US) 2026-04-23 US claimed
EP-2948149-B1 TOXIC ALDEHYDE RELATED DISEASES AND TREATMENT ALDEYRA THERAPEUTICS INC (US) 2026-03-04 EP claimed
US-20260014120-A1 COMPOSITIONS AND METHODS FOR TOPICAL DELIVERY OF SALTS OF CARNOSINE AND CARNITINE NeuviDerm LLC (US) 2026-01-15 US claimed
WO-1996028187-A1 METHOD FOR TREATING AMYLOIDOSIS QUEEN'S UNIVERSITY AT KINGSTON (CA) 1996-09-19 WO claimed
US-5395742-A IMAGEWISE EXPOSURE OF A PHOTOGRAPHIC MATERIAL TO LIGHT FUJI PHOTO FILM CO., LTD. (JP) 1995-03-07 US claimed
EP-0626374-A2 A diaminostilbene series compound and a method for forming an image using the same FUJI PHOTO FILM CO., LTD. (JP) 1994-11-30 EP claimed
US-5312722-A Ketone imine dyes FUJI PHOTO FILM CO., LTD. (JP) 1994-05-17 US claimed
EP-0569857-A1 Silver halide photographic material FUJI PHOTO FILM CO., LTD. (JP) 1993-11-18 EP claimed
US-5147454-A Bath comprising mixture of alkanesulfonic acids or alkanolsulfonic acids, a tin salt thhereof, a lead salt thereof, a thiourea derivative and a mono-, di-, or tricarboxylic acid or salt thereof OKUNO CHEMICAL INDUSTRIES CO., LTD. (JP) 1992-09-15 US claimed
EP-0222970-B1 SULPHOALKYLATION PROCESS Agfa-Gevaert AG (DE) 1990-10-24 EP claimed
EP-0222970-A1 Sulphoalkylation process Agfa-Gevaert AG (DE) 1987-05-27 EP claimed
EP-0034279-B1 SULFOALKYLATING AGENTS, PROCESS FOR THEIR PREPARATION AND THEIR USE IN THE MANUFACTURE OF QUANTERNARY SULFOALKYL SALTS Agfa-Gevaert AG (DE) 1983-06-22 EP claimed
US-4171459-A Manufacture of α-naphthol BASF AKTIENGESELLSCHAFT (DE) 1979-10-16 US claimed